Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Debt Ratio (2016 - 2017)

Corcept Therapeutics (CORT) has disclosed Debt Ratio for 6 consecutive years, with 0.05 as the latest value for Q2 2017.

  • Quarterly Debt Ratio fell 86.53% to 0.05 in Q2 2017 from the year-ago period, while the trailing twelve-month figure was 0.05 through Jun 2017, down 86.53% year-over-year, with the annual reading at 0.21 for FY2016, 59.74% down from the prior year.
  • Debt Ratio hit 0.05 in Q2 2017 for Corcept Therapeutics, down from 0.13 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.98 in Q4 2014 to a low of 0.05 in Q2 2017.
  • Historically, Debt Ratio has averaged 0.51 across 5 years, with a median of 0.51 in 2013.
  • Biggest five-year swings in Debt Ratio: surged 91.27% in 2014 and later crashed 86.53% in 2017.
  • Year by year, Debt Ratio stood at 0.56 in 2013, then soared by 76.03% to 0.98 in 2014, then plummeted by 45.87% to 0.53 in 2015, then plummeted by 59.74% to 0.21 in 2016, then tumbled by 75.22% to 0.05 in 2017.
  • Business Quant data shows Debt Ratio for CORT at 0.05 in Q2 2017, 0.13 in Q1 2017, and 0.21 in Q4 2016.